Abciximab reduces procedure time among patients undergoing percutaneous coronary intervention.

Journal Article

Full Text

Duke Authors

Cited Authors

  • Cabot, CF; Anderson, KM; Tcheng, JE; Lincoff, AM

Published Date

  • September 22, 1999

Published In

Volume / Issue

  • 84 / 6A

Start / End Page

  • 71P - 71P

International Standard Serial Number (ISSN)

  • 0002-9149